Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations.

نویسندگان

  • A Hagemeijer
  • E M Smit
  • B Löwenberg
  • J Abels
چکیده

A 6.5.yr follow-up study is reported on a case of chronic myeloid leukemia (CML) diagnosed in 1971 in a man of age of 19 yr. At that time the Ph1 chromosome was found in all of his bone marrow cells. After 4 yr of intermittent treatment his blood and bone marrow still showed a florid CML picture, but the karyotypes of bone marrow, blood, and spleen cells were normal. Blastic transformation occurred after 5.5 yr and was accompanied by a hyperdiploid karyotype (49,XY,+9,+1O,+12) without reappearance of the Ph1 chromosome. After successful chemotherapy the karyotype again became normal. In 1977 cells with a new clonal aberration (l4p+) gradually became the dominating bone marrow cell population, while the peripheral blood was compatible with CML. The 14p+ clone subsequently decreased at the expense of the 49,XY,+9,+ 10,+ 12 clone, which had reappeared in the majority of the dividing blood cells. Also, a new clonal subpopulation 45,XY,t(5p; 1 7q) was found in 7% of the metaphases. This coincided with the occurrence of a second blast transformation, which was treated with chemotherapy. The karyotypes of all dividing cells during the recovery from the induced severe bone marrow hypoplasia still showed the t( 5p; 1 7q) abnormality and chromosome numbers varying from 45 to 51. In some cells additional trisomies were seen as an indication of a clonal evolution. One month before the patient’s death a fourth abnormal cell line was seen in 10% of the dividing blood cells.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Investigation of SMAD3 and SMAD4 genes expression in CML patients and K562 cell line and association with chronic myeloid leukemia

Aim and Background: Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder with cytogenetic characterization of the abnormal Philadelphia chromosome. This chromosome results from a reciprocal translocation between chromosomes 9 and 22. This is an important signaling pathway in the process of cancer cell proliferation and apoptosis, as well as the pathogenesis of TGF-β disease, i...

متن کامل

Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell.

It has been shown with glucose 6-phosphate dehydrogenase (G-6-PD) mosaicism that Ph1-positive chronic myelogenous leukemia (CML) is a clonal disease that involves multipotent hematopoietic stem cells. We now report G-6-PD studies of a 79-yr-old woman with Ph1-negative CML. Equal amounts of B and A-type activities were found in nonhematopoietic tissues, indicating that the patient was heterozygo...

متن کامل

Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemia.

Treatment with recombinant human interferon alpha-A (Roferon-A) is associated with stable suppression of the population of cells that display the Philadelphia (Ph1) chromosome in some patients with chronic myelogenous leukemia (CML) as defined by cytogenetic analysis. Southern blot analyses employing a 3' breakpoint cluster region (bcr) probe (Pr-1) were performed to confirm a complete suppress...

متن کامل

Signaling pathways involved in chronic myeloid leukemia pathogenesis: the importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells

Objective(s): Chronic myeloid leukemia (CML) is a myeloid clonal proliferation disease defining by the presence of the Philadelphia chromosome that shows the movement of BCR-ABL1. In this study, the critical role of the Musashi2-Numb axis in determining cell fate and relationship of the axis to important signaling pathways such as Hedgehog and Notch that are essential ...

متن کامل

Analysis of Expression Of SIRT1 Gene In Patients With Chronic Myeloid Leukemia Resistant To Imatinib Mesylate

Background: Chronic myeloid leukemia is a clonal myeloproliferative disease which is characterized by bcr/abl translocation. With the emergence of tyrosine kinase inhibitors such as imatinib mesylate, significant improvement has been made in treatment of this disease. However, drug resistance against this medicine is still an obstacle. SIRT1 is a gene with deacetylase activity which has been de...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Blood

دوره 53 1  شماره 

صفحات  -

تاریخ انتشار 1979